You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 1, January 1988 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Short-term Hemodynamic Effects of Captopril in Infants With Congestive Heart Failure

Robert E. Shaddy, MD; David F. Teitel, MD; Claire Brett, MD

Am J Dis Child. 1988;142(1):100-105.


Abstract



• We studied the short-term hemodynamic effects of captopril in ten infants with congestive heart failure secondary to large left-to-right shunts who were refractory to routine medical management with digoxin and diuretics. During cardiac catheterization, captopril (0.5 to 1.0 mg/kg) was administered by nasogastric tube. For the entire group, mean systemic blood flow, pulmonary blood flow, and the pulmonary-to-systemic blood flow ratio did not change significantly after captopril administration. However, in the seven patients in whom baseline systemic vascular resistance was greater than 20 U/m2, captopril decreased the pulmonary-to-systemic blood flow ratio. In contrast, in the three patients in whom baseline systemic vascular resistance was less than 20 U/m2, captopril increased the pulmonary-to-systemic blood flow ratio. We conclude that captopril acutely decreases the pulmonary-to-systemic blood flow ratio in infants with large left-to-right shunts who have elevated systemic vascular resistance. Renal function must be monitored closely when using captopril.

(AJDC 1988;142:100-105)



Author Affiliations



From the Department of Pediatrics and the Cardiovascular Research Institute, University of California, San Francisco. Dr Shaddy is now with the University of Utah, Salt Lake City.


Footnotes



Accepted for publication Sept 1, 1987.

Reprint requests to Department of Pediatric Cardiology, 2A152 Medical Center, University of Utah, 50 N Medical Dr, Salt Lake City, UT 84132 (Dr Shaddy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.